Patents by Inventor Ken Rivlin

Ken Rivlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Single Chain Fv constructs of anti-ganglioside GD2 antibodies
    Publication number: 20030147808
    Abstract: Recombinant antibody constructs comprise the variable regions of the heavy and light chains of anti-GD2 antibodies. These antibody constructs may be coupled to a label such as a radiolabel or to a protein such as streptavidin or pro-drug converting enzymes for use in imaging or therapeutic applications. The antibody constructs may also be transduced into T cells to produce populations of T cells which target GD2-producing tumor cells.
    Type: Application
    Filed: February 13, 2002
    Publication date: August 7, 2003
    Inventors: Nai-Kong V. Cheung, Steven M. Larson, Hong-Fen Guo, Ken Rivlin, Michel Sadelain
  • Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
    Patent number: 6451995
    Abstract: Recombinant antibody constructs comprise the variable regions of the heavy and light chains of anti-GD2 antibodies. These antibody constructs may be coupled to a label such as a radiolabel or to a protein such as streptavidin or pro-drug converting enzymes for use in imaging or therapeutic applications. The antibody constructs may also be transduced into T cells to produce populations of T cells which target GD2-producing tumor cells.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: September 17, 2002
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Nai-Kong V. Cheung, Steven M. Larson, Hong-Fen Guo, Ken Rivlin, Michel Sadelain